{"id":7622,"date":"2024-06-11T10:49:42","date_gmt":"2024-06-11T08:49:42","guid":{"rendered":"https:\/\/www.msd.ch\/fr\/?page_id=7622"},"modified":"2024-06-11T10:49:43","modified_gmt":"2024-06-11T08:49:43","slug":"welireg-publication-of-clinical-trial-results","status":"publish","type":"page","link":"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/","title":{"rendered":"WELIREG\u00ae &#8211; Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques<\/h1>\n\n\n\n<p>Les informations ci-dessous ainsi que les liens correspondant aux donn\u00e9es cliniques r\u00e9pondent aux exigences des articles 71 \u00e0 73 de l\u2019Ordonnance sur les m\u00e9dicaments (Ordonnance sur les m\u00e9dicaments, OM\u00e9d) et compl\u00e8tent les informations publi\u00e9es en lien avec l\u2019autorisation suisse des m\u00e9dicaments correspondants.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">WELIREG\u00ae<\/h2>\n\n\n\n<p>Welireg\u00ae (belzutifan), comprim\u00e9s pellicul\u00e9s, chaque comprim\u00e9 pellicul\u00e9 contient 40 mg de belzutifan.<\/p>\n\n\n\n<p>Num\u00e9ro d\u2019autorisation: 68531<\/p>\n\n\n\n<p>Swissmedic Date d&#8217;autorisation: 21 mars 2024<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><br>\u00c9tudes cliniques<\/h4>\n\n\n\n<p><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT03401788\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)<\/a><br>NCT03401788<\/p>\n\n\n\n<p><strong>Publication<\/strong>:<br>Jonasch E, Dosnkov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, Oudard S, Else T, Maranchie JK, Welsh SJ, Thamake S, Park EK, Perini RF, Linehan WM, Srinivasan R; MK-6482-004 Investigators. Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. N Engl J Med. 2021 Nov 24;385(22):2036-2046. doi:10.1056\/NEJMoa2103425.<\/p>\n\n\n\n<p><sup>CH-BEL-00025, 06\/2024<\/sup><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques Les informations ci-dessous ainsi que les liens correspondant aux donn\u00e9es cliniques r\u00e9pondent aux exigences des articles 71 \u00e0 73 de l\u2019Ordonnance sur les m\u00e9dicaments (Ordonnance sur les m\u00e9dicaments, OM\u00e9d) et compl\u00e8tent les informations publi\u00e9es en lien avec l\u2019autorisation suisse des m\u00e9dicaments correspondants. WELIREG\u00ae Welireg\u00ae (belzutifan), comprim\u00e9s pellicul\u00e9s, chaque comprim\u00e9 pellicul\u00e9 [&hellip;]<\/p>\n","protected":false},"author":974,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"editor_notices":[],"footnotes":""},"class_list":["post-7622","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>WELIREG\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch<\/title>\n<meta name=\"description\" content=\"Publication des r\u00e9sultats d&#039;\u00e9tudes cliniques sur Welireg\u00ae (belzutifan), autoris\u00e9 par Swissmedic le 21 mars 2024.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WELIREG\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch\" \/>\n<meta property=\"og:description\" content=\"Publication des r\u00e9sultats d&#039;\u00e9tudes cliniques sur Welireg\u00ae (belzutifan), autoris\u00e9 par Swissmedic le 21 mars 2024.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"msd.ch\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-11T08:49:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/\",\"url\":\"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/\",\"name\":\"WELIREG\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch\",\"isPartOf\":{\"@id\":\"https:\/\/www.msd.ch\/fr\/#website\"},\"datePublished\":\"2024-06-11T08:49:42+00:00\",\"dateModified\":\"2024-06-11T08:49:43+00:00\",\"description\":\"Publication des r\u00e9sultats d'\u00e9tudes cliniques sur Welireg\u00ae (belzutifan), autoris\u00e9 par Swissmedic le 21 mars 2024.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.msd.ch\/fr\/#website\",\"url\":\"https:\/\/www.msd.ch\/fr\/\",\"name\":\"msd.ch\",\"description\":\"MSD recherche et d\u00e9veloppe des m\u00e9dicaments et des vaccins pour sauver des vies et am\u00e9liorer la sant\u00e9 des patients. En Suisse, 1000 employ\u00e9s \u00e0 Lucerne et \u00e0 Zurich s&#039;engagent dans ce sens.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.msd.ch\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WELIREG\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","description":"Publication des r\u00e9sultats d'\u00e9tudes cliniques sur Welireg\u00ae (belzutifan), autoris\u00e9 par Swissmedic le 21 mars 2024.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/","og_locale":"en_US","og_type":"article","og_title":"WELIREG\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","og_description":"Publication des r\u00e9sultats d'\u00e9tudes cliniques sur Welireg\u00ae (belzutifan), autoris\u00e9 par Swissmedic le 21 mars 2024.","og_url":"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/","og_site_name":"msd.ch","article_modified_time":"2024-06-11T08:49:43+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/","url":"https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/","name":"WELIREG\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","isPartOf":{"@id":"https:\/\/www.msd.ch\/fr\/#website"},"datePublished":"2024-06-11T08:49:42+00:00","dateModified":"2024-06-11T08:49:43+00:00","description":"Publication des r\u00e9sultats d'\u00e9tudes cliniques sur Welireg\u00ae (belzutifan), autoris\u00e9 par Swissmedic le 21 mars 2024.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.msd.ch\/fr\/welireg-publication-of-clinical-trial-results\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.msd.ch\/fr\/#website","url":"https:\/\/www.msd.ch\/fr\/","name":"msd.ch","description":"MSD recherche et d\u00e9veloppe des m\u00e9dicaments et des vaccins pour sauver des vies et am\u00e9liorer la sant\u00e9 des patients. En Suisse, 1000 employ\u00e9s \u00e0 Lucerne et \u00e0 Zurich s&#039;engagent dans ce sens.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.msd.ch\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/7622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/users\/974"}],"replies":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/comments?post=7622"}],"version-history":[{"count":2,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/7622\/revisions"}],"predecessor-version":[{"id":7624,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/7622\/revisions\/7624"}],"wp:attachment":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/media?parent=7622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}